2013 || Aarkstore.in || Orphan Drugs in Asia-Pacific: From Designation to Pricing - PowerPoint PPT Presentation

About This Presentation
Title:

2013 || Aarkstore.in || Orphan Drugs in Asia-Pacific: From Designation to Pricing

Description:

Aarkstore.in announces Latest report -Orphan Drugs in Asia-Pacific: From Designation to Pricing – PowerPoint PPT presentation

Number of Views:102
Slides: 10
Provided by: Lavanya86
Category:

less

Transcript and Presenter's Notes

Title: 2013 || Aarkstore.in || Orphan Drugs in Asia-Pacific: From Designation to Pricing


1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, industry research, SWOT analysis, and
so on Aarkstore.com is in the forefront as it
is enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Category
  • Pharmaceuticals Healthcare Market Research
    Reports http//www.aarkstore.co
    m/market-sector-reports/Pharmaceuticals--Healthca
    re-7.html

3
Report
2013 Orphan Drugs in Asia-Pacific From
Designation to Pricing Aarkstore.in
http//aarkstore.in/Orphan-Drugs-in-Asia-Pacifi
c-Designation-to-Pricing.html
4
Request Sample
http//www.aarkstore.com/Report/SampleRequest.asp?
RptId91588
5
Summary
  • A major new report Orphan Drugs in
    Asia-Pacific From designation to pricing,
    funding and market access focuses on five
    developed markets in the region Japan, South
    Korea, Taiwan, Singapore and Australia. Each has
    passed specific measures to promote the
    development, registration and/or
    commercialisation of rare disease treatments.
    Singapores Medicines (Orphan Drug) Exemption
    Order of 1991 was the first legislation anywhere
    to follow the US Orphan Drug Act, with the other
    four Asia-Pacific countries also implementing
    orphan-promoting measures ahead of the EU.
    More

6
Table of Contents
  • 1. Introduction  2. Japan  2.1
    Healthcare and Health Insurance System  2.2
    Orphan Drug Legislation  2.2.1 Orphan Drug
    Development Programme, 1993  2.2.2 Qualifying
    Criteria  2.2.3 Procedure/Timetable  2.2.4
    Incentives  2.2.4.1 RD Support  2.2.4.2
    Protocol Assistance  2.2.4.3 Expedited
    Regulatory Review  2.2.4.4 Lower Regulatory Fees
     2.2.4.5 Market Exclusivity
    More

7
Latest Reports
http//www.aarkstore.com/publishers/JustPharmaRepo
rts-12.html Pharmaceutical Pricing, Reimbursement
Distribution in Poland, 2010 and BeyondOrphan
Drugs in Asia-Pacific From Designation to
Pricing, Funding Market AccessDistribution
and Patient Support for Speciality Medicines in
EuropeProspects for Legalizing Drug
(Re-)Importation to the United StatesComplete
Guide to the 2009 PPRS, NICE other
Pharmaceutical Cost Containment Measures in the
United Kingdom
8
(No Transcript)
9
Contact us
For More details about above other Reports
please contact Lavanya Aarkstore.com Contact
Marketing team Mob.No.918149852585 Email
Customersupport_at_aarkstore.com URL
http//www.aarkstore.com
http//aarkstore.in/
Write a Comment
User Comments (0)
About PowerShow.com